Navigation Links
BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases

Madison WI (PRWEB) May 10, 2013

Join us for a webinar on May 15, 2013 at 12:00 PM EDT.

An Integrated instrument-Reagent Platform for Screening and Profiling Kinases and Methyltransferases

Register now!

Biochemical HTS assays are a critical component of drug discovery programs focused on enzyme targets like kinases and methyltransferases. Assembling high quality assay reagents and validating them on a detection platform that can deliver speed, accuracy and reproducibility can consume a significant amount of time and resources. The shift toward screening focused libraries against multiple targets in parallel can add to the assay development burden substantially.

In this webinar, you will learn:

  • How Transcreener HTS Assays allow robust, initial velocity detection of any kinase or methyltransferase enzyme.
  • How to sync Transcreener assays with BMG’s Pherastar Plus plate reader to generate high quality screening or profiling data.
  • How to use Pherastar’s onboard software to determine IC50 values directly from raw assay data without constructing a standard curve.
  • How to eliminate costly biochemical assay development using turnkey kits combining Transcreener assays and pre-calibrated kinase and methyltransferase enzymes and substrates.

Participants should come away confident that they can apply a robust, cost-effective, user friendly solution to immediately begin screening/profiling multiple kinases or methyltransferases in parallel.

After registering, you will receive a confirmation email containing information about joining the webinar.

About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.

About BMG LABTECH. BMG LABTECH is ‘The Microplate Company’. Since we are committed to producing microplate readers you can be assured that we will provide you with the best detection that German engineering can provide. The PHERAstar line of microplate readers are our top of the line multi-functional readers for high-throughput screening; providing you with high sensitivity and fast read-times in all detection modes. The PHERAstar employs assay specific optic modules that have been optimized to perform well whether your test detects fluorescence intensity, fluorescence polarization, time-resolved FRET or many other detection modes.

For more information about the variety of microplate readers that BMG LABTECH offers, please visit our website:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
2. Flexible Sensors Offer Unprecedented View of Brain Activity During Epileptic Seizures
3. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
4. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
5. Fortis Offers Bachelor of Science in Nursing Degree Program to Florida Students
6. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
7. At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
8. iBio, Inc. Prices $10 Million Public Offering
9. UH Case Medical Center Offers New Therapy for Gynecologic Cancer Patients
10. Sequenom Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
11. Spherix Announces Registered Direct Offering of $1.15 Million
Post Your Comments:
(Date:11/24/2015)... 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... president and chief executive officer, will present at the 27 ... New York City . The presentation will ... 2015 at 9:30 a.m. EST. and ... at least 15 minutes prior to the presentation to allow ...
(Date:11/24/2015)... According to two new studies, fewer men are having PSA ... doctors, scientists, and public health experts have been pushing for ... being done, will there be more men dying of ... "Despite the efforts made in regards to early detection for ... of death in men, killing approximately 27,500 men this year. ...
(Date:11/23/2015)... 2015 China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the second quarter and ... 2015. --> --> ... for the second quarter of fiscal 2016 increased by ...
(Date:11/23/2015)... , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... for a hepatitis C medicine, signing an agreement with Bristol-Myers ... to help cure multiple genotypes of the HCV virus.  The ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):